Evidence map›Paper›PMID 10417273›Full record

ArticleAmerican journal of human genetics1999

Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene.

A Colige, A L Sieron, S W Li, U Schwarze, E Petty, W Wertelecki, W Wilcox, D Krakow, D H Cohn, W Reardon and 4 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in American journal of human genetics, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 123 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
123citing papers in PubMed, 2 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

123 citing papers in PubMed, 2 syntheses or guidelines pooled it, 363 citations in OpenAlex.

  1. Vascular phenotypes in nonvascular subtypes of the Ehlers-Danlos syndrome: a systematic review.Genetics in medicine : official journal of the American College of Medical Genetics · 2018
    Pooled it
  2. Pooled it
  3. Physiology (Bethesda, Md.) · 2026
    Review
  4. AnBiomedicines · 2026
    Article
  5. Bone matrix proteins: regulators of skeletal remodeling and repair.Journal of bone and mineral metabolism · 2026
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. ProteinMolecules (Basel, Switzerland) · 2025
    Review
  12. Genetic diagnosis of the Ehlers-Danlos syndromes.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. Expression Profiling ofIranian journal of public health · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Novel HomozygousGenes · 2022
    Article

63 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

A ColigeLaboratory of Connective Tissues Biology, University of Liège, Liège, Belgium.
A L Sieron
S W Li
U Schwarze
E Petty
W Wertelecki
W Wilcox
D Krakow
D H Cohn
W Reardon
P H Byers
C M Lapière
D J Prockop
B V Nusgens
Allegheny College · USCedars-Sinai Medical Center · USUniversity of Liège · BEUniversity of Washington · USUniversity College London · GBUniversity of Michigan–Ann Arbor · USUniversity of South Alabama · US

Funding

THE SKELETAL DYSPLASIASP01HD022657 · NICHD · CEDARS-SINAI MEDICAL CENTER · PI RIMOIN, DAVID L · 1987 to 2011
$17.0M
STRUCTURAL PROTEINS IN DISORDERS OF KERATINIZATIONP01AR021557 · NIAMS · UNIVERSITY OF WASHINGTON · PI SMITH, LYNNE · 1986 to 2001
$2.8M
GENETIC AND MOLECULAR BASIS OF OSTEOGENESIS IMPERFECTAR01AR039837 · NIAMS · CEDARS-SINAI MEDICAL CENTER · PI COHN, DANIEL H · 1993 to 1996
–
GENETIC AND MOLECULAR BASIS OF OSTEOGENESIS IMPERFECTAR29AR039837 · NIAMS · CEDARS-SINAI MEDICAL CENTER · PI COHN, DANIEL H · 1988 to 1992
–
NIAMS NIH HHS AR 21557NIAMS NIH HHS AR 39837NICHD NIH HHS HD 22657
6 · The paper itself

Abstract

Ehlers-Danlos syndrome (EDS) type VIIC is a recessively inherited connective-tissue disorder, characterized by extreme skin fragility, characteristic facies, joint laxity, droopy skin, umbilical hernia, and blue sclera. Like the animal model dermatosparaxis, EDS type VIIC results from the absence of activity of procollagen I N-proteinase (pNPI), the enzyme that excises the N-propeptide of type I and type II procollagens. The pNPI enzyme is a metalloproteinase containing properdin repeats and a cysteine-rich domain with similarities to the disintegrin domain of reprolysins. We used bovine cDNA to isolate human pNPI. The human enzyme exists in two forms: a long version similar to the bovine enzyme and a short version that contains the Zn++-binding catalytic site but lacks the entire C-terminal domain in which the properdin repeats are located. We have identified the mutations that cause EDS type VIIC in the six known affected human individuals and also in one strain of dermatosparactic calf. Five of the individuals with EDS type VIIC were homozygous for a C-->T transition that results in a premature termination codon, Q225X. Four of these five patients were homozygous at three downstream polymorphic sites. The sixth patient was homozygous for a different transition that results in a premature termination codon, W795X. In the dermatosparactic calf, the mutation is a 17-bp deletion that changes the reading frame of the message. These data provide direct evidence that EDS type VIIC and dermatosparaxis result from mutations in the pNPI gene.

Indexed as

MutationAlternative SplicingAmino Acid SequenceAnimalsCattleCattle DiseasesCells, CulturedCloning, MolecularCodon, TerminatorDisease Models, AnimalDNA Mutational AnalysisEhlers-Danlos SyndromeFibroblastsGenotypeHumansInfantCodon, TerminatorProcollagen N-EndopeptidaseRNA, Messenger

Identifiers

PMID10417273
PMCPMC1377929
OpenAlexW2081172215

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.